Skip to content
OpenCapital
Get started

Select Medical Holdings SEM Payments For Repurchase Of Equity

Payments For Repurchase Of Equity at other companies

Concentra Group Holdings Parent logo
Concentra Group Holdings ParentCON
——

Other financials

Income statement

See full
Revenue$1.4B+5.0%
Gross profit$175.5M-2.8%
Operating income$98.4M-12.7%
Net income$44.0M-22.4%
EPS (diluted)$0.35-20.5%

Balance sheet

See full
Cash & equivalents$25.7M-51.7%
Total debt$3.0B+7.5%
Total equity$1.8B+2.1%
Total assets$6.0B+6.1%

Cash flow

See full
Operating cash flow$37.9M+1,195%
CapEx$58.9M+12.5%
Free cash flow-$21.0M+62.3%

Valuation

See full
Market cap$2.05B-6.2%

Profitability

See full
Gross margin11.3%-0.5pp
Operating margin5.8%+0.8pp
Net margin2.4%-0.9pp
FCF margin2.8%-4.1pp

Returns & leverage

See full
Return on equity7.7%-3.6pp
Debt / equity1.7×+0.1×
Current ratio1.1×0.0×

Where this comes from

Reported directly by Select Medical Holdings in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfEquity.

The official record: Select Medical Holdings’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Select Medical Holdings's payments for repurchase of equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Select Medical Holdings's payments for repurchase of equity?
Select Medical Holdings (SEM) reported payments for repurchase of equity of $0 in Q1 2026.
How has Select Medical Holdings's payments for repurchase of equity changed year-over-year?
Select Medical Holdings's payments for repurchase of equity decreased by 100.0% year-over-year, from $11.39M to $0.
What is the long-term trend for Select Medical Holdings's payments for repurchase of equity?
Over 4 years (2021 to 2025), Select Medical Holdings's payments for repurchase of equity has grown at a 5.9% compound annual growth rate (CAGR), from $79.48M to $100.08M.